AmpliMed (Tucson, AZ) a clinical-stage pharmaceutical company with Phase II lead compounds for malignant melanoma and pancreatic cancer closed on $5M traunche of a $22M Series C financing. Participants include BioMed Venture Partners, Biotech Insight Ventures, Solstice Capital and Valley Ventures.
AmpliMed Corp.: Series C $22.0M
January 20, 2008
Leave a Comment » | 
I - Series C, R - SOUTH WEST, X - Oncology | 
Permalink
Posted by arubenstein
Cayenne Medical, Inc.: Series B $12.7M
March 2, 2007Cayenne Medical (Scottsdale, AZ) medical device company focused on ACL fixation raised $12.7M in Series B funding. Participants included Split Rock Partners and MB Venture Partners.
Leave a Comment » | 
I - Series B, R - SOUTH WEST, X - Device (Orthopedic) | 
Permalink
Posted by arubenstein
